“…For example, clonidine decreases craving, anxiety, tension, irritability, and restlessness associated with nicotine withdrawal (Glassman et al, 1984). More recently, administration of clonidine or other α 2 -adrenergic receptor agonists (e.g., lofexidine, guanfacine, guanabenz) has been demonstrated to attenuate stress-induced reinstatement of opiate, cocaine, and alcohol seeking in rats (Erb et al, 2000; Highfield, Yap, Grimm, Shalev, & Shaham, 2001; Lé et al, 2005; Shaham et al, 2000). These results are consistent with evidence that blocking post-synaptic α 1 -adrenergic receptors with prazosin decreases consumption of cocaine, opiates, nicotine, and alcohol (Greenwell, Walker, Cottone, Zorrilla, & Koob, 2009; Rasmussen et al, 2009; Simpson et al, 2009; Villégier, Lotfipour, Belluzzi, & Leslie, 2007; Wee, Mandyam, Lekic, & Koob, 2008; Zhang & Kosten, 2005, 2007) and with the findings of the current study that inhibiting noradrenergic signaling with the α 2 -adrenergic receptor agonist, clonidine, decreases voluntary alcohol consumption.…”